Joel A Sincavage

Array ( [id] => 8352055 [patent_doc_number] => 08247384 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-21 [patent_title] => 'Methods and compositions for wound healing' [patent_app_type] => utility [patent_app_number] => 11/985717 [patent_app_country] => US [patent_app_date] => 2007-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 38343 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11985717 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5331500 [patent_doc_number] => 20090111977 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-30 [patent_title] => 'ANTISENSE COMPOUND FOR INDUCING IMMUNOLOGICAL TOLERANCE' [patent_app_type] => utility [patent_app_number] => 11/941033 [patent_app_country] => US [patent_app_date] => 2007-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13901 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20090111977.pdf [firstpage_image] =>[orig_patent_app_number] => 11941033 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4825665 [patent_doc_number] => 20080124734 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-29 [patent_title] => 'Stable Cell Lines and Methods for Evaluating Gastrointestinal Absorption of Chemicals' [patent_app_type] => utility [patent_app_number] => 11/938065 [patent_app_country] => US [patent_app_date] => 2007-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 25963 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20080124734.pdf [firstpage_image] =>[orig_patent_app_number] => 11938065 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 43999 [patent_doc_number] => 07776837 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-17 [patent_title] => 'RNA aptamers and methods for identifying the same' [patent_app_type] => utility [patent_app_number] => 11/936015 [patent_app_country] => US [patent_app_date] => 2007-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 50 [patent_no_of_words] => 31414 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/776/07776837.pdf [firstpage_image] =>[orig_patent_app_number] => 11936015 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4808140 [patent_doc_number] => 20080171718 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-17 [patent_title] => 'Methods and Compositions for Treating Cancer Using BCL-2 Antisense Oligomers, Tyrosine Kinase Inhibitors, and Chemotherapeutic Agents' [patent_app_type] => utility [patent_app_number] => 11/935654 [patent_app_country] => US [patent_app_date] => 2007-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5009 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20080171718.pdf [firstpage_image] =>[orig_patent_app_number] => 11935654 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4574651 [patent_doc_number] => 07855184 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-12-21 [patent_title] => 'Antisense oligonucleotides capable of inhibiting the formation of capillary tubes by endothelial cells and methods of treating ophthalmic and dermatological diseases' [patent_app_type] => utility [patent_app_number] => 11/931844 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 23 [patent_no_of_words] => 7185 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/855/07855184.pdf [firstpage_image] =>[orig_patent_app_number] => 11931844 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4764637 [patent_doc_number] => 20080175848 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-24 [patent_title] => 'Methods for treating conditions associated with the accumulation of excess extracellular matrix' [patent_app_type] => utility [patent_app_number] => 11/981283 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 19429 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20080175848.pdf [firstpage_image] =>[orig_patent_app_number] => 11981283 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 203021 [patent_doc_number] => 07632938 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-15 [patent_title] => 'siRNA targeting superoxide dismutase 1 (SOD1)' [patent_app_type] => utility [patent_app_number] => 11/978518 [patent_app_country] => US [patent_app_date] => 2007-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 34189 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/632/07632938.pdf [firstpage_image] =>[orig_patent_app_number] => 11978518 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4834144 [patent_doc_number] => 20080132691 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-05 [patent_title] => 'siRNA targeting kinase insert domain receptor (KDR)' [patent_app_type] => utility [patent_app_number] => 11/978107 [patent_app_country] => US [patent_app_date] => 2007-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 34979 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20080132691.pdf [firstpage_image] =>[orig_patent_app_number] => 11978107 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 43988 [patent_doc_number] => 07776836 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-17 [patent_title] => 'RNA aptamers and methods for identifying the same' [patent_app_type] => utility [patent_app_number] => 11/925648 [patent_app_country] => US [patent_app_date] => 2007-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 45 [patent_no_of_words] => 31359 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/776/07776836.pdf [firstpage_image] =>[orig_patent_app_number] => 11925648 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 83682 [patent_doc_number] => 07741307 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-22 [patent_title] => 'RNA aptamers and methods for identifying the same' [patent_app_type] => utility [patent_app_number] => 11/925645 [patent_app_country] => US [patent_app_date] => 2007-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 45 [patent_no_of_words] => 31313 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/741/07741307.pdf [firstpage_image] =>[orig_patent_app_number] => 11925645 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4846401 [patent_doc_number] => 20080182809 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-31 [patent_title] => 'RNA APTAMERS AND METHODS FOR IDENTIFYING THE SAME' [patent_app_type] => utility [patent_app_number] => 11/925641 [patent_app_country] => US [patent_app_date] => 2007-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 31435 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20080182809.pdf [firstpage_image] =>[orig_patent_app_number] => 11925641 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7599701 [patent_doc_number] => 07582746 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-01 [patent_title] => 'siRNA targeting complement component 3 (C3)' [patent_app_type] => utility [patent_app_number] => 11/978070 [patent_app_country] => US [patent_app_date] => 2007-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 34425 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/582/07582746.pdf [firstpage_image] =>[orig_patent_app_number] => 11978070 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4570044 [patent_doc_number] => 07858591 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-12-28 [patent_title] => 'RNA aptamers and methods for identifying the same' [patent_app_type] => utility [patent_app_number] => 11/925651 [patent_app_country] => US [patent_app_date] => 2007-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 45 [patent_no_of_words] => 31347 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/858/07858591.pdf [firstpage_image] =>[orig_patent_app_number] => 11925651 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4939589 [patent_doc_number] => 20080076908 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-27 [patent_title] => 'siRNA targeting nuclear receptors' [patent_app_type] => utility [patent_app_number] => 11/977347 [patent_app_country] => US [patent_app_date] => 2007-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 39914 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20080076908.pdf [firstpage_image] =>[orig_patent_app_number] => 11977347 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8469861 [patent_doc_number] => 08299040 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-30 [patent_title] => 'Methods for treating cancer targeting transglutaminase' [patent_app_type] => utility [patent_app_number] => 11/867717 [patent_app_country] => US [patent_app_date] => 2007-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 32 [patent_no_of_words] => 27211 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11867717 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5398471 [patent_doc_number] => 20090318534 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'METHODS AND COMPOSITIONS FOR THE TREATMENT OF SKIN DISEASES AND DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/443312 [patent_app_country] => US [patent_app_date] => 2007-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 13299 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20090318534.pdf [firstpage_image] =>[orig_patent_app_number] => 12443312 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4786469 [patent_doc_number] => 20080139798 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-12 [patent_title] => 'siRNA targeting myeloid cell leukemia sequence 1' [patent_app_type] => utility [patent_app_number] => 11/903001 [patent_app_country] => US [patent_app_date] => 2007-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 28430 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0139/20080139798.pdf [firstpage_image] =>[orig_patent_app_number] => 11903001 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4697784 [patent_doc_number] => 20080219968 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-11 [patent_title] => 'Sos1 inhibitors' [patent_app_type] => utility [patent_app_number] => 11/903498 [patent_app_country] => US [patent_app_date] => 2007-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 27163 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20080219968.pdf [firstpage_image] =>[orig_patent_app_number] => 11903498 [rel_patent_id] =>[rel_patent_doc_number] =>)